Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hemodialysis as kidney replacement therapy].

C Descoeudres1

  • 1Abteilung für Dialyse und Transplantation, Medizinische Poliklinik der Universität Bern.

Schweizerische Medizinische Wochenschrift
|August 8, 1989
PubMed
Summary

Haemodialysis (artificial kidney treatment) is a vital renal replacement therapy for end-stage renal failure. While effective for long-term survival, it requires significant patient commitment and lifestyle adjustments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Factors determining the choice of a modality of treatment by dialysis: a study of nine dialysis centers].

Nephrologie·2000
Same author

Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients.

Transplantation·1997
Same author

Six-month overnight administration of intraperitoneal amino acids does not improve lean mass.

Clinical nephrology·1996
Same author

Effect of calcium-channel blockers on calcium-phosphate metabolism in patients with end-stage renal disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1996
Same author

Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·1996
Same author

Impact of time-interval after transplantation and therapy with fibrates on serum cholesterol levels in renal transplant patients.

Clinical nephrology·1993

Area of Science:

  • Nephrology
  • Biomedical Engineering

Context:

  • Haemodialysis is the primary renal replacement therapy in Europe, supporting over 80,000 patients with end-stage renal failure.
  • The procedure involves extracorporeal removal of uraemic toxins using a semipermeable membrane filter.
  • Treatment is administered thrice weekly, lasting 3-4 hours, and can be done at home or in clinical settings.

Purpose:

  • To describe the mechanism, application, and patient experience of haemodialysis.
  • To highlight the benefits and drawbacks of haemodialysis as a life-sustaining treatment.
  • To contextualize haemodialysis within the broader scope of renal replacement therapies.

Summary:

  • Haemodialysis utilizes an artificial kidney to filter waste products and excess fluid from the blood for patients with kidney failure.
  • This therapy enables long-term survival and a reasonable quality of life for many patients.
  • Despite its effectiveness, haemodialysis imposes significant time constraints, dietary restrictions, and patient dependency.

Impact:

  • Haemodialysis significantly extends the lifespan of patients with end-stage renal failure.
  • The treatment regimen impacts patients' daily lives, necessitating lifestyle modifications and support systems.
  • Patient desire for kidney transplantation underscores the challenges associated with long-term dialysis therapy.

Related Experiment Videos